Outcomes of stereotactic body radiotherapy for bone oligometastases in older patients − A European multicenter cohort study

Radiotherapy and Oncology 2026 Open access

Read full text
Authors: Franziska Nägler, Sebastian Schäfer, Isabell Seiler, Camilla von Wachter, Panagiotis Balermpas, Mauro Loi, Pierluigi Bonomo, Marek Slávik, Petr Burkon, Lena Kästner, Johannes Meents, Fabian Lohaus
+24 more Jochen Willner, Anna Sabrina Schunn, Sophia Drabke, Kenneth Klischies, Olaf Wittenstein, Priska Bank, Richard Partl, Jörg Andreas Müller, Ahmed Gawish, Arne Grün, Andrea Baehr, Maike Trommer, Eleni Gkika, Thomas Mader, Richard Holý, Bernd Frerker, Felix Ehret, Alexander Rühle, Matthias Guckenberger, Christos Moustakis, Thomas B. Brunner, Oliver Blanck, Judit Boda-Heggemann, Nils H. Nicolay
DOI: 10.1016/j.radonc.2026.111485
Cited by: 2
References: 50

Abstract

INTRODUCTION: Outcome patterns for stereotactic body radiotherapy (SBRT) of bone oligometastases (BoM) especially for older patients are inadequately defined. We aimed to evaluate oncological outcomes and tolerability of SBRT for BoM in older patients. MATERIAL AND METHODS: Patients ≥70 years treated with SBRT for BoM between 2010 and 2024 at 20 European centers were analyzed and compared to patients

Fields of Study & Subjects

Management of metastatic bone disease Medical Imaging Techniques and Applications Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
Radiotherapy and Oncology
Publisher
Elsevier BV
Volume
219
Pages
111485–111485
Publication date
14 March 2026
Language
EN